ReviewMagma (New York, N.Y.)2026
Advanced methods in deuterium metabolic imaging.
Review in Magma (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Physics-embedded CycleGAN for robust metabolite mapping in short-readout deuterium metabolic imaging.Magnetic resonance letters · 2026Article
- On the Origin of the Brain Semi-Heavy Water Deuterium MR Signal Following Administration of Deuterated Metabolic Substrate: A Cautionary Tale.Magnetic resonance in medicine · 2026Article
- Deuterium metabolic imaging beyond the brain: mapping tissue metabolism across the body.Magma (New York, N.Y.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDeuterium metabolic imaging (DMI) has recently been established as a versatile MR-based technique for in vivo mapping of glucose and other metabolic pathways using safe, non-ionizing
objectiveIn this review, methodological advances in DMI over the past decade are summarized, spanning hardware, acquisition, reconstruction, and quantification. APPROACH AND OUTLINE: Developments in multinuclear system modifications and dual-tuned head and body coils that enable 3D DMI at clinical and ultra-high field strengths are outlined. Efficient spatial-spectral encoding strategies and balanced steady-state-free-precession-based MRSI, which improve SNR efficiency and spatiotemporal resolution, are reviewed together with temporally interleaved OUTLOOK: Current strategies for concentration estimation, kinetic modeling, and treatment of label loss are discussed, positioning DMI as a promising complement to FDG-PET and
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.